March 14, 2012 (Shanghai) - The world renowned analytical instrument manufacturer, Agilent Technologies announced today that its President and Chief Executive Officer, Mr. William P. (Bill) Sullivan, paid a visit during his current China trip to the newly opened Chinese National Compound Library (CNCL), located at the heart of Shanghai Zhangjiang High-tech Park. Together with Mr. Jianjun Cheng, Deputy Director of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Mr. Jing Hou, Deputy Director of Shanghai Zhangjiang INNOPARK Administrative Committee and Mr. Huo Feng, Vice President and General Manager of Great China Area of Agilent, he unveiled the plate of the "CNCL-Agilent Advanced Technology Collaboration Laboratory”.

Accompanied by Mr. Xiangdong Fu, Vice President in charge of Corporate Relations and Business Development and other Agilent colleagues, Mr. Sullivan and Mr. Huo visited the CNCL facility in the afternoon of March 14, 2012, and received a warm reception by Mr. Jianjun Cheng, Mr. Jing Hou and Dr. Ming-Wei Wang. Following an introduction relative to the history, development and prospect of CNCL by Dr. Wang, Mr. Sullivan expressed his great pleasure to make such a visit. He briefly discussed the recent developments of Agilent both in China and globally, as well as its future growth strategies. "Agilent pays tremendous attention and attaches significant importance to the potential and growth trend of Chinese pharmaceutical industry. I hope to strengthen bilateral cooperation and jointly promote drug discovery and development, for the advancement of sciences and betterment of human health", said Mr. Sullivan.

On behalf of Academician Jian Ding, Professor Yang Ye, Deputy Director of  Shanghai Institute of Materia Medica, Chinese Academy of Sciences warmly welcomed all the guests and offered his sincere congratulations to the collaboration set forth between CNCL and Agilent Technologies. He wishes that this mutually beneficial and win-win partnership will strengthen the technical competence of both parties with an ultimate goal of serving people’s needs.

Dr. Ming-Wei Wang and Mr. Feng Huo signed the collaboration agreement. In the name of Agilent Technologies, Mr. Huo donated a variety of scientific equipment and laboratory consumables to CNCL. "Life science is the cornerstone of Agilent’s global strategy which is best exemplified by the establishment of this Advanced Technology Collaboration Laboratory", said Mr. Huo.

Among the list of distinguished guests are: Mr. Guofeng Tao (Deputy Director, Overseas Chinese Affairs Office, Shanghai Municipal People’s Government), Mr. Lanzhong Wang (General Manager, Zhangjiang State Biotech and Pharmaceutical Industrial Base, on behalf of Mr. Lei Ding, President of Shanghai Zhangjiang (Group) Co., Ltd.), Mr. Weihua Song (Assistant Director, Shanghai Zhangjiang INNOPARK Administrative Committee), Madam Yingzi Hua (Section Chief of Personnel Division, Organization Department of Pudong District CPC Committee), Mr. Jianxiang Huang (Deputy Director of Pudong District Overseas Chinese Affairs Office), Madam Shirley Zhao (Director of Business Development Center, Shanghai Zhangjiang (Group) Co., Ltd.) and Mr. Gang Liu (Secretary General, Shanghai Pudong Bio Industry Association).

As an important resource and information center for drug discovery in China, CNCL promotes the growth of Chinese pharmaceutical industry by providing high-quality professional services to clients around the world. Agilent is a leading high-tech company specializing in analytical measurement, instrumentation and technical services. In recent years, Agilent has become a global player in life sciences and analytical chemistry, among others. The establishment of the Advanced Technology Collaboration Laboratory will certainly enhance bilateral cooperation and joint development. At present, this collaborative laboratory is equipped with analytical HPLC, preparation HPLC, LC/MS and automation workstation manufactured by Agilent, representing the best match of the world’s most advanced analytical instrumentation and the first class of Chinese research capability. Such an integration and utilization of both domestic and international resources will definitely ensure an sustained development of pharmaceutical industry.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,700 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.

About the Chinese National Compound Library

The Chinese National Compound Library (CNCL), located at the Pharma Valley of China – Shanghai Zhangjiang High-tech Park, is a major research and development establishment managed by the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Shanghai Zhangjiang Biopharmaceutical Base Development, Co., Ltd. Its storage capacity will exceed one million compounds possessing diversified structures within a few years. Coupled with this library will be advanced sample handling, information management and quality control systems. For further information please visit www.cncl.org.cn.

Speech by Mr. Jing Hou

Speech by Mr. Bill Sullivan

Signing of the collaboration agreement

Unveil of the collaboration laboratory plate

Group picture